Mizoram University Researchers Identify Repurposed Drug Targets for COVID-19
A research team from Mizoram University from northwestern India recently published the results of a study titled, ‘Step toward repurposing […]
Nitazoxanide (NT-300) Trial Comes to Northern Alabama as Cullman Clinical Trials Launches COVID-19 Targeting Study
Another antiparasitic drug has emerged as a potential treatment for COVID-19, and trial site organization in Cullman, Alabama, called Cullman […]
Sanford Burnham Prebys Discovers 21 Drugs that Could Treat COVID-19 Including Clofazimine, Hanfangchin A, Apilimod and ONO 5334
Sanford Burnham Prebys Medical Discovery Institute’s Sumit Chanda, PhD led a powerful team of scientists that have identified at least […]
Scripps & Calibr Select AI-based Drug Discovery Platform to Identify Repurposed Drugs targeting COVID-19
Scripps Research, recently ranked as the most influential institution in the world for innovation by Nature Index, selected Repurpose.AI to […]
The Move to Repurpose Drugs to Treat the Novel Coronavirus: Status
NBC News recently reported that along with the big push for new COVID-19 vaccines, there are a number of initiatives […]
Broad Institute’s Drug Repurposing Lab Key for Compelling Study Identifying Nearly Fifty Non-Oncology Drugs that May Fight Cancer
Research scientists from the Broad Institute of MIT, Harvard, and Dana-Farber Cancer Institute have concluded from a recent study that […]
Many Costly Drugs Derived from Older Approved Drugs: Is Innovation Waning?
Drug prices continue to go up
George Washington University Study Asks: Can Nilotinib be Repurposed from use for Specific Cancer to use for Parkinson’s Disease?
There is tremendous value in identifying new purposes for existing drugs. Recently, Georgetown University Medical Center (GUMC) embarked on a project […]
CURE ID Launched by FDA to Open up Crowdsourcing for Repurposing of Approved Drugs for Novel Uses in Rare Disease
The U.S. Food and Drug Administration announced the launch of CURE ID, an internet-based repository that enables the clinical community to […]
